Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy
- Written by PR Newswire
![]() |
- Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembrolizumab treatment response
SEOUL, South Korea, Oct. 27, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a research...